Germline variants in childhood melanoma
Whole-exome sequencing was performed on DNA extracted from blood samples of 50 children diagnosed with cutaneous melanoma prior to 18 years of age. Patients were all diagnosed in Queensland, Australia, and self-reported as of European descent. Sequencing was done the Illumina platform using SureSelct V7 Post capture kits.
- 6 samples
- DAC: EGAC00001001088
- Technology: Illumina NovaSeq 6000
Access to data is available by application to the Data Access Committee (DAC). Access can be granted to qualified investigators with an established scientific record for appropriate use in a manner approved by their institutional human subjects research ethics committee.
Access to data is available by application to the Data Access Committee (DAC). Access can be granted to qualified investigators with an established scientific record for appropriate use in a manner approved by their institutional human subjects research ethics committee. 1. The data can only be used for the purpose of medical research, according to the consent given by the donor. 2. The data cannot be used for commercial purposes or for development of products for sale. 3. Investigators cannot transfer or disclose the data, in whole or in part, to a third party (who should make a separate application to the DAC). 4 In any work based on this data, the published article from which the data derives should be acknowledged appropriately.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Exome Sequencing |